Publications by authors named "Peter C Smits"

Claim this Profile
F
Frequency of periprocedural myocardial injury and infarction stratified by cardiac troponin I and cardiac troponin T.
Pruthvi C Revaiah, Tsung-Ying Tsai, Bo Wang, Mick Renkens, Shigetaka Kageyama, Peter C Smits

Cardiovasc Revasc Med· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A prospective study comparing short versus standard dual antiplatelet therapy in patients with acute myocardial infarction: design and rationale of the TARGET-FIRST trial.
Giuseppe Tarantini, Peter Cornelius Smits, Thibault Lhermusier, Benjamin Honton, Grégoire Rangé

EuroIntervention· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Defining Strategies of Modulation of Antiplatelet Therapy in Patients With Coronary Artery Disease: A Consensus Document from the Academic Research Consortium.
Davide Capodanno, Roxana Mehran, Mitchell W Krucoff, Usman Baber, Deepak L Bhatt, Peter C Smits

Circulation· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardiac complications in patients hospitalised with COVID-19.
Marijke Linschoten, Sanne Peters, Maarten van Smeden, Lucia S Jewbali, Jeroen Schaap, Peter C Smits

Eur Heart J Acute Cardiovasc Care· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mid-term outcomes of the Absorb BVS versus second-generation DES: A systematic review and meta-analysis.
Cordula M Felix, Victor J van den Berg, Sanne E Hoeks, Jiang Ming Fam, Mattie Lenzen, Peter C Smits

PLoS One· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Potentially increased incidence of scaffold thrombosis in patients treated with Absorb BVS who terminated DAPT before 18 months.
Cordula M Felix, Georgios J Vlachojannis, Alexander J J IJsselmuiden, Jiang M Fam, Peter C Smits

EuroIntervention· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Two-year outcomes after deployment of XIENCE V everolimus-eluting stents in patients undergoing percutaneous coronary intervention of bifurcation lesions: a report from the SPIRIT V single arm study.
Vladimír Džavík, Upendra Kaul, Guilio Guagliumi, Bernard Chevalier, Peter C Smits

Catheter Cardiovasc Interv· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The SPIRIT V diabetic study: a randomized clinical evaluation of the XIENCE V everolimus-eluting stent vs the TAXUS Liberté paclitaxel-eluting stent in diabetic patients with de novo coronary artery lesions.
Eberhard Grube, Bernard Chevalier, Giulio Guagliumi, Peter C Smits, Marrianne Stuteville

Am Heart J· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Trends in prevalence of cardiovascular risk factors and their treatment in coronary heart disease: the Euroaspire-project].
Jaap W Deckers, Rinus J Veerhoek, Peter C Smits, Chris G Jansen

Ned Tijdschr Geneeskd· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and feasibility of transendocardial autologous bone marrow cell transplantation in patients with advanced heart disease.
Shmuel Fuchs, Ran Kornowski, Giora Weisz, Lowell F Satler, Peter C Smits

Am J Cardiol· March 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence of thrombotic stent occlusion during the first three months after sirolimus-eluting stent implantation in 500 consecutive patients.
Evelyn Regar, Pedro A Lemos, Francesco Saia, Muzaffer Degertekin, Kengo Tanabe, Peter C Smits

Am J Cardiol· May 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Persistent inhibition of neointimal hyperplasia after sirolimus-eluting stent implantation: long-term (up to 2 years) clinical, angiographic, and intravascular ultrasound follow-up.
Muzaffer Degertekin, Patrick W Serruys, David P Foley, Kengo Tanabe, Evelyn Regar, Peter C Smits

Circulation· September 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis